L
54
5
DOW
47
4
TRV
34
4
GOOG
77
14
EA
41
3
UNH
42
6
THC
52
9
NTAP
58
3
NOV
45
2
PWR
63
3
GM
55
6
ETN
64
4
FE
34
4
ZBH
69
15
PCG
59
9
HBI
53
4
MTB
38
4
LEN
21
3
IR
46
3
HPE
48
2
L
54
5
DOW
47
4
TRV
34
4
GOOG
77
14
EA
41
3
UNH
42
6
THC
52
9
NTAP
58
3
NOV
45
2
PWR
63
3
GM
55
6
ETN
64
4
FE
34
4
ZBH
69
15
PCG
59
9
HBI
53
4
MTB
38
4
LEN
21
3
IR
46
3
HPE
48
2
Financhill
Back

Mithra Pharmaceuticals SA 10K Form

Sell
35

MITPF
Mithra Pharmaceuticals SA

Last Price:
$6.75
Seasonality Move:
6.36%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive MITPF News And Ratings

See the #1 stock for the next 7 days that we like better than MITPF

MITPF Financial Statistics

Sales & Book Value

Annual Sales: $70.7M
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $0.00
Price / Book: 0

Profitability

Net Income (TTM): $0
Gross Margin: $50M
Return on Equity: 0%
Return on Assets: 0%

Mithra Pharmaceuticals SA Earnings Forecast

Key Mithra Pharmaceuticals SA Financial Ratios

  • The Gross Profit Margin over the past 11 years for MITPF is 70.71%.
  • The Selling, General & Administrative Expenses for MITPF have been equal to 25.04% of Gross Profit Margin.
  • The Research & Development expenses have been 95.59% of Revenue.
  • The Interest Expense is -28.52% of Operating Income.
  • The Net Earning history of MITPF is -88.99% of Total Revenues.
  • Per Share Earnings over the last 11 years have been positive in 3 years.

Mithra Pharmaceuticals SA Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: MITPF
Website: mithra.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

MITPF Technical Analysis vs Fundamental Analysis

Sell
35
Mithra Pharmaceuticals SA (MITPF) is a Sell

Is Mithra Pharmaceuticals SA a Buy or a Sell?